Description
A searchable, sortable database that reveals the identities of companies worldwide developing exosome therapies, diagnostics and platform technologies.
Exosomes are small vesicles ranging from 30-100nm in size that are found in nearly all eukaryotic fluids and facilitate a range of important cellular functions. They transfer DNA, RNA, and proteins to other cells, thereby altering the function of the targeted cells.
In recent years, exosomes have been gaining momentum as a strategy for accessing the therapeutic effects of cells without the risks and difficulties of administering the cells to patients. With at least 12,431 scientific articles published about exosomes and 128 clinical trials underway, these small vesicles have intriguing potential to be used within a range of therapeutic applications.
Exosomes are also coming under increasing scrutiny from the U.S. FDA, with a Public Safety Notification on Exosome Products released December 6, 2019. As stated by the FDA: “There are currently no FDA-approved exosome products. Certain clinics across the country, including some that manufacture or market violative ‘stem cell’ products, are now also offering exosome products to patients.”
Global Database of Exosome Companies
This is a global database of exosome companies that we originally developed for our own purposes. Because more and more of our readers have been requesting access to it, we are now making it accessible.
The database features companies who are developing exosome and extracellular vesicle (EV) therapies, diagnostics and platform technologies.
The database features the following information for all known exosome market competitors, including:
- Company Name
- City / State
- Country
- Company Website
- Type of Exosome Technology
- Description of Exosome Technology
- Link to Website Describing Company’s Exosome Program
Use this list of exosome companies to:
- Identify global competitors within the exosome marketplace
- Quantify exosome products in early and late stage development
- Identify regions that are “hotspots” for exosome therapies
- Understand partnerships and co-development programs for exosome technologies
- Identify M&A activity within the exosome industry
- Identify exosome companies that may or may not be in compliance with FDA Standards
Database of Exosome Companies
It takes our team of analysts hours of research to uncover these exosome companies from across the globe.
Act now and your searchable, sortable Excel database will be available for immediate download with printing rights allowed.
Of course, your investment is backed by our 60-Day Money Back Guarantee.
*Database updated on 03/31/2020.
